Lung Cancer Diagnostics Market
Lung Cancer Diagnostics Market Study by CA Tests, HER2 Tests, ALK Tests, Angiogenesis Inhibitors, EGFR Mutation Tests, and KRAS Mutation Tests from 2024 to 2034
Analysis of Lung Cancer Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationLung Cancer Diagnostics Market Outlook (2024 to 2034)
Growing awareness about the importance of accurate and early diagnosis of cancer is set to drive global demand for lung cancer diagnostics, with the market reaching a value of US$ 2.98 billion in 2024. The global lung cancer diagnostics market size has been projected to expand at a CAGR of 6.1% and end up at US$ 5.4 billion by 2034.
Technological advancements taking place in diagnostic technology, including the discovery of new biomarkers and the development of various non-invasive diagnostic methods are set to generate lucrative opportunities for suppliers of lung cancer diagnostic services. Rising concentration on early detection, diagnosis, and supportive treatment for lung cancer is anticipated to positively attract lung cancer diagnostics market trends.
Rising cases of lung cancer along with the growing count of private diagnostic laboratories is estimated to increase demand for lung cancer diagnostics. Various primary care doctors and governments in developed countries are recommending tests for cancer screening for patients, which is anticipated to drive opportunities for market players.
- Demand for lung cancer diagnostics in Canada is evaluated to increase at a CAGR of 7.5% from 2024 to 2034.
- Hospital-associated labs are forecasted to account for 46.9% of the lung cancer diagnostics market share by the end of 2034.
- North America is projected to lead with 37.3% share of the global market by 2034-end.
Market players are investing more in the diagnosis and development of novel therapeutic options to ensure the delivery of effective treatment options. Moreover, advancements taking place in imaging technology are set to contribute to the development of accurate imaging techniques, including low-dose CT scans, etc. These advancements are projected to help in the detection of earlier and smaller-stage tumors.
Development of innovative and new biomarkers to detect lung cancer at early stages is contributing to market dynamics. In addition, the use of these biomarkers in multiple blood tests, including liquid biopsy, etc. is estimated to improve the effectiveness and accuracy of lung cancer diagnostics and assist in developing personalized treatment.
| Report Attributes | Details |
|---|---|
| Lung Cancer Diagnostics Market Size (2024E) | US$ 2.98 Billion |
| Forecasted Market Value (2034F) | US$ 5.4 Billion |
| Global Market Growth Rate (2024 to 2034) | 6.1% CAGR |
| Market Share of EGFR Mutation Tests (2034F) | 28.2% |
| South Korea Market Growth Rate (2024 to 2034) | 7.5% CAGR |
| South Asia & Pacific Market Share (2034F) | 21% |
| Key Companies Profiled | NeoGenomics Laboratories, Inc.; Illumina, Inc.; Danaher Corporation; Abbott Laboratories; Roche Holding AG; Quest Diagnostics Incorporated; Myriad Genetics, Inc.; Thermo Fischer Scientific, Inc.; NanoString Technologies, Inc.; QIAGEN N.V. |
Which Market Dynamics are Shaping the Prospects of Lung Cancer Diagnostic Solution Providers?
“Rising Spending on Treatment Offered for Lung Cancer”
In recent years, there have been numerous patients, who are spending significantly on research conducted for cancer treatment, which is set to offer remunerative opportunities for suppliers of related products and services. Further, there is a significant number of lung cancer patients, who have been diagnosed at advanced stages are not treated by surgery or some other therapeutic options. Accessibility to government and private funds for conducting R&D activities for the development of more effective tumor diagnostic tools is estimated to support the development of diagnostics to minimize the cost of screening.
“Adoption of Advanced Multimodal Diagnostic Approaches”
Adoption of some advanced multimodal diagnostic techniques is anticipated to influence lung cancer diagnostics demand positively. For example, the development of breath analysis and liquid biopsy is estimated to lead to more advanced and promising technologies, which help in detecting biomarkers related to lung cancer. AI and wearable devices are two niches, which need standardization and development for commercialization. Particles, fibers, and robots, are some of the nano-systems included in upcoming technology for detecting lung cancer.
Which Hurdles are Encountered by Providers of Lung Cancer Diagnostics?
“High Prices of Diagnostic Tests and Availability of Alternative Methods”
Cost of lung cancer diagnostics is comparatively higher than other available options. In addition, the easy availability of numerous alternative diagnostic methods at pocket-friendly prices is estimated to limit the expansion of the lung cancer diagnostics market size.
How are New Companies Making a Name for Themselves in the Global Market?
“Higher Expenditure on R&D Activities for Product Innovation”
New market players trying to enter the market are investing in R&D activities for the development of improved and new diagnostic methods to enrich their product portfolio and increase their market share in the forecasted period.
Country-wise Insights
As mentioned in Fact.MR published research report, North America is projected to account for 37.3% share of the global market by 2034. Increasing cases of lung cancer in the region are generating demand for accurate and early diagnosis, which is further driving demand for lung cancer diagnostics. Furthermore, the presence of a well-established healthcare system is also contributing to market growth.
Why are Diagnostic Solution Providers Targeting the United States?
“Supportive Policies Leading to Development of Advanced Cancer Treatment”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 915 Million |
| Growth Rate (2024 to 2034) | 5.8% CAGR |
| Projected Value (2034F) | US$ 1.6 Billion |
The United States is approximated to hold 85.1% share of the market in North America by the end of 2034. Constant efforts by various private as well as government associations to implement supportive initiatives are projected to generate opportunities for players. The easy availability of funds for researchers for researching to develop ways for quick analysis of data collected from gene sequencing and identification of mutations in genes of lung cancer are attracting market trends. These research activities are forecasted to pave the way for finding novel treatments against lung cancer.
Why is China a Key Market in East Asia?
“Rising Cases of Non-small Cell Lung Cancer Generating Treatment Requirements”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 233.9 Million |
| Growth Rate (2024 to 2034) | 9.6% CAGR |
| Projected Value (2034F) | US$ 586.7 Million |
China is evaluated to contribute 55.8% share of the market in East Asia by 2034. NSCLC (non-small cell lung cancer) is a commonly diagnosed cancer in China, which is contributing to increased demand for effective treatment options. Continuous uptake along with anticipated approvals for inhibitors of immune checkpoints is estimated to drive market growth there.
Category-wise Insights
As mentioned in the research report published by Fact.MR, a market research and competitive intelligence provider, demand for non-small-cell lung cancer diagnostics is projected to increase at a CAGR of 5.9% and reach a market value of US$ 4.41 billion by the end of the forecast period in 2034.
Why are EGFR Mutation Tests Preferred More by Healthcare Providers?
“Convenience and Efficiency of EGFR Mutation Testing”
| Attribute | EGFR Mutation Tests |
|---|---|
| Segment Value (2024E) | US$ 879.3 Million |
| Growth Rate (2024 to 2034) | 5.6% CAGR |
| Projected Value (2034F) | US$ 1.52 Billion |
EGFR mutation tests are forecasted to hold 28.2% share of global market revenue by the end of 2034. The rising prominence of these tests is attributed to the convenience offered to healthcare providers. Clinicians are provided with two options using either plasma or tissue as biopsy samples. Moreover, this test makes the entire processing of collected samples more efficient and convenient.
Which End User Accounts for High Lung Cancer Diagnostics Market Growth Decisively?
“High Popularity of Hospital-associated Labs among Patients”
| Attribute | Hospital Associated Labs |
|---|---|
| Segment Value (2024E) | US$ 1.5 Billion |
| Growth Rate (2024 to 2034) | 5.3% CAGR |
| Projected Value (2034F) | US$ 2.53 Billion |
Hospital-associated labs are calculated to enjoy a share of 46.9% of the global market by 2034-end. The rising count of cancer patients visiting hospitals along with increasing incidences of in-house diagnostics processes conducted in hospitals is contributing to the preference to hospital-associated labs. Furthermore, growing awareness related to early diagnosis is also contributing to increased demand for lung cancer diagnostics in hospital-associated labs.
Competitive Landscape
New product development, maintaining supply chain systems, and quality control are some of the prominent strategies adopted by players to retain existing customers and generate new leads. Leading market players are embracing various innovative approaches, including technological advancements for cancer screening, acquisitions, mergers, and ground-breaking marketing tactics.
For instance :
- Geneseeq Technology Inc. is one of the prominent providers of NGS (next-generation sequencing) precision oncology. In March 2021, it entered into a collaboration with Illumina, Inc. for the development of a comprehensive IVD (in-vitro diagnostic) NGS testing kit for cancer with the use of the sequencing platform of Illumina.
Key players in the lung cancer diagnostics market are NeoGenomics Laboratories, Inc., Illumina, Inc., Danaher Corporation, Abbott Laboratories, Roche Holding AG, Quest Diagnostics Incorporated, Myriad Genetics, Inc., Thermo Fischer Scientific, Inc., NanoString Technologies, Inc., and QIAGEN N.V.
Segmentation of Lung Cancer Diagnostics Market Research
-
By Test Type:
- CA Tests
- HER2 Tests
- ALK Tests
- Angiogenesis Inhibitors
- EGFR Mutation Tests
- KRAS Mutation Tests
-
By End User:
- Hospital-Associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
-
By Indication:
- Non-small-cell Lung Cancer
- Small-cell Lung Cancer
-
By Region:
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Test Type
- 5.1. CA Tests
- 5.2. HER2 Tests
- 5.3. ALK Tests
- 5.4. Angiogenesis Inhibitors
- 5.5. EGFR Mutation Tests
- 5.6. KRAS Mutation Tests
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Indication
- 6.1. Non-small-cell Lung Cancer
- 6.2. Small-cell Lung Cancer
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
- 7.1. Hospital-Associated Labs
- 7.2. Independent Diagnostic Laboratories
- 7.3. Cancer Research Institutes
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. NeoGenomics Laboratories, Inc.
- 16.2. Illumina, Inc.
- 16.3. Danaher Corporation
- 16.4. Abbott Laboratories
- 16.5. Roche Holding AG
- 16.6. Quest Diagnostics Incorporated
- 16.7. Myriad Genetics, Inc.
- 16.8. Thermo Fischer Scientific, Inc.
- 16.9. NanoString Technologies, Inc.
- 16.10. QIAGEN N.V.
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034
- FAQs -
How big is the size of the lung cancer diagnostics market in 2024?
The global lung cancer diagnostics market is poised to reach US$ 2.98 billion in 2024.
What is the sales outlook for lung cancer diagnostics for 2034?
Worldwide revenue from lung cancer diagnostics is projected to reach US$ 5.4 billion by 2034.
What is the projected growth rate for the global market?
The global market is forecasted to advance at 6.1% CAGR from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is anticipated to hold 37.3% of global market share by 2034.
What is the demand projection for lung cancer diagnostics in South Korea?
Demand for lung cancer diagnostics in South Korea is estimated to increase at a 7.5% CAGR from 2024 to 2034.
How much share of the global market is anticipated to be held by hospital-associated labs?
Hospital-associated labs are calculated to account for 46.9% share of global market revenue by 2034.
What is the best diagnostic for lung cancer?
Low-dose computed tomography (LDCT or low-dose CT scan) is one of the most effective screening tests used against lung cancer.
Lung Cancer Diagnostics Market